PharmaHub · Other Pharma & Biotech · Global

Lab Automation Market: Market Size & Forecast 2026

The global lab automation market encompasses the hardware, software, and integrated systems used to streamline laboratory workflows across pharmaceuticals, biotechnology, clinical diagnostics, and academic research. Valued at approximately $7.13 billion in 2025, the market is projected to grow at roughly 8.2% annually, propelled by rising demand for high-throughput testing, laboratory workforce shortages, and expanding R&D investment. The sector spans automated workstations, liquid handling systems, microplate readers, and laboratory information management systems (LIMS) designed to boost throughput, reduce human error, and cut operational costs.

Market size · 2025
$7.1 billion
CAGR · 2025–2030
8.2%
Forecast · 2030
$10.6 billion
Basis
Claight Analysis
Market size (USD)
Base year 2025
Official data · Claight AnalysisForecast
Market size and forecast are Claight Analysis, informed by public research.
Forecast
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2025 base: $7.1bn2030 est: $10.6bn
Read the full Lab Automation Market report →

Market Overview

Lab automation refers to the use of robotics, software platforms, and integrated instruments to perform routine and complex laboratory tasks with minimal human intervention. The market encompasses pre-analytical instruments, analytical automation tools, storage and retrieval systems, and software solutions including Laboratory Information Management Systems (LIMS) and Electronic Lab Notebooks (ELN). These technologies serve clinical chemistry laboratories, diagnostic centers, pharmaceutical manufacturing facilities, and academic research institutions seeking to standardize processes, accelerate turnaround times, and maintain regulatory compliance.

  • Product categories include automated workstations, liquid handling systems, microplate readers, and LIMS/ELN software platforms
  • Applications span drug discovery and development, clinical diagnostics, genomics and proteomics research, and quality control testing
  • The market has attracted significant investment as laboratories look to replace manual workflows with robotic and software-driven solutions

Growth Drivers

Persistent shortages of skilled laboratory personnel are a primary catalyst, pushing organizations toward automation as a means of maintaining productivity despite constrained headcount. The rising complexity of drug discovery programs and expanding omics research have intensified demand for high-throughput screening capabilities that only automation can reliably deliver. Additional tailwinds come from the global push toward personalized medicine, which requires the processing of vastly larger sample volumes with greater accuracy, as well as increasingly stringent regulatory requirements around data integrity and traceability.

  • Workforce shortages across clinical and research laboratories are accelerating adoption of automated platforms
  • High-throughput screening demands in drug discovery and diagnostic testing drive investment in scalable automation systems
  • Stringent quality compliance standards and personalized medicine initiatives are making automation a necessity rather than a luxury
Want a deeper cut on Lab Automation Market? We build bespoke studies on request.
Connect to an analyst →

Segmentation and Regional Analysis

North America commands the largest share of the global lab automation market, supported by substantial pharmaceutical R&D spending, a dense concentration of biotechnology companies, and mature healthcare infrastructure. Europe represents the second-largest regional market, with strong adoption driven by clinical laboratory consolidation and pharmaceutical manufacturing operations. The Asia-Pacific region is expected to record the fastest growth rate, fueled by expanding biotech sectors in China and India, increasing healthcare infrastructure investment, and growing numbers of contract research organizations serving multinational pharmaceutical clients.

  • North America leads in market share, with Europe following and Asia-Pacific emerging as the fastest-growing regional segment
  • Product-wise, the market spans automated workstations and liquid handling systems alongside software platforms including LIMS and ELN
  • Key end-user industries include pharmaceutical and biotechnology companies, clinical and hospital laboratories, and academic research institutions

Trends and Outlook

What are the recent trends and outlook?

Integration of artificial intelligence and machine learning into laboratory automation systems is emerging as a transformative trend, enabling predictive maintenance, intelligent sample routing, and real-time quality monitoring that enhance overall system efficiency. Cloud-based LIMS and ELN platforms are gaining momentum as laboratories seek remote accessibility, interoperability, and scalable data storage solutions. The convergence of lab automation with robotics, the miniaturization of assay systems, and growing adoption of continuous manufacturing in pharmaceutical production are expected to further reshape the competitive and technological landscape.

  • AI and ML integration is enabling smarter automation systems capable of adaptive workflow optimization and predictive maintenance
  • Cloud-based software platforms and digital twins are improving laboratory connectivity, data management, and remote operation capabilities
  • Miniaturization of lab processes and integration of single-use technologies are reducing costs and increasing flexibility for high-volume applications
Talk to a Claight analyst
Do you want to research Lab Automation Market?

Get in touch and our analysts will be happy to help with custom market sizing, deeper segmentation, supplier detail or a bespoke study built for you.

Connect to an analyst →

Market size and forecast are Claight Analysis, informed by public research and industry data. Historical years before 2025 and all forecast years are Claight estimates at the stated CAGR. Retrieved 2026.